Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Work detail
This page groups all known editions belonging to the same underlying work.
Overview
Shared work-level identity and catalog context.
Contributors
People credited with this work in the active catalog.
- Open Author
Robert Giffin
- Open Author
Sally Robinson
- Open Author
Institute of Medicine
- Open Author
Board on Health Sciences Policy
- Open Author
Forum on Drug Discovery, Development, and Translation
- Open Author
Theresa Wizemann
Editions
Publication-specific versions linked to this work only.
- BBBreakthrough Business Models :...Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Robert Giffin, Sally Robinson
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
- BBBreakthrough Business Models :...Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Robert Giffin, Sally Robinson
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
- BBBreakthrough Business Models :...Forum on Drug Discovery, Development, and Translation, Robert Giffin, Sally Robinson, Theresa Wizemann, Board on Health Sciences Policy
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
- BBBreakthrough Business Models :...Sally Robinson
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies